Healthcare Pharmaceutical Biotech

Who Provides The Best Breast Lift Surgery in Sarasota?

August 12, 2026 6:00 AM

Choosing a breast lift surgeon involves more than comparing before-and-after photos or procedure pricing. As breast lift surgery in Sarasota becomes one of the most frequently requested procedures, patients are increasingly evaluating surgeons based on board certification, surgical experience, incision technique, and the ability to produce natural-looking results. Based on these publicly available factors, Dr. Alberico J. Sessa of Sarasota...

Read more

AlzeCure Receives a Total Upfront Payment of USD 12 million and Completes the Initial Transaction with QuantumCell

August 12, 2026 4:15 AM

AlzeCure Pharma AB ("AlzeCure" or "The Company") (STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, announced today that it has now received the full upfront payment of USD 12 million from the Danish biotech company QuantumCell ApS. The payment is made pursuant to the licensing and collaboration agreement for the NeuroRestore Alzheimer's platform, including the lead...

Read more

Athens Bioscience Unlocks Automated Citation Tracking and High-Impact Publication Insights with Bioz

August 12, 2026 4:00 AM

Bioz, Inc., the platform transforming publication data into trusted product validation, announced its collaboration with Athens Bioscience, Inc., a leading provider of life science research products and solutions. Through the implementation of Bioz Badges and Bioz Content Hubs across its newly redesigned website, Athens Bioscience is providing researchers with direct access to publication-backed validation while automating the tracking of...

Read more

Tashiba Williams Highlights ADA Family Health Clinic's Mobile Wound Care Model Reshaping Healthcare Economics

August 12, 2026 3:05 AM

Tashiba Williams, NP-C, founder of ADA Family Health Clinic, is highlighting the clinic's mobile approach to chronic wound care as an economic model for addressing inefficiencies in America's healthcare system. By bringing specialized wound care directly to patients' homes, ADA Family Health Clinic reduces hospitalizations, surgical complications, and costs associated with untreated chronic wounds. The conventional healthcare system responds to...

Read more

Theralogix Expands Its Women's Health Line with Two Breakthrough NSF-Certified Formulas

August 12, 2026 12:00 AM

Theralogix, a leader in evidence-based nutritional supplements, announced the launch of two new additions to its Women's Health Collection: Magnesium L-Theanine Complex™, a targeted formula for relaxation and restful sleep, and TreBiome™, an advanced synbiotic for full-spectrum microbiome support.* Both formulas are based on clinical research, backed by science, and rigorously tested and certified by NSF International. For more than two decades,...

Read more

CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids

August 11, 2026 10:30 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "our", "us" or "we"), a consumer health company specializing in science-backed natural ingredients and products, today announced the launch of PlusHLTH.com, a new direct-to-consumer destination dedicated exclusively to the Company's growing +PlusHLTH™ product line. The launch of PlusHLTH.com represents an important milestone in the Company's long-term strategy to expand beyond cannabinoids and...

Read more

Dr. Oz's Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte's Web Hemp Extract

August 11, 2026 10:10 PM

MMJ International Holdings, Inc. ("MMJ") today called on Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz and CMS to explain why the federal government is expanding access to hemp derived cannabinoid products for Medicare beneficiaries when those commercial products have not undergone the rigorous FDA drug-development process required of pharmaceutical medicines. The question has taken on new urgency following Administrator...

Read more

Vogenx Announces Pricing of Initial Public Offering

August 11, 2026 7:20 PM

Vogenx, Inc. (NASDAQ:VOGX) ("Vogenx"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at the high end of the range at a public offering...

Read more

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026

August 11, 2026 4:05 PM

Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today highlighted recent corporate progress and reported financial results for the second quarter ended June 30, 2026. "Over the past year, we have transformed Dermata through a strategic pivot to become a commercial-stage, direct-to-consumer skincare company," commented Gerry Proehl, Dermata's Chairman, President, and CEO....

Read more

Alter Behavioral Health Integrates Care Predictor Index Across Clinical and Residential Treatment Programs

August 11, 2026 10:30 AM

Alter Behavioral Health, a leading mental health treatment network, today announced the integration of the Care Predictor Index (CPI) across its clinical and residential treatment programs. This novel assessment tool marks a pivotal shift in mental health care, moving beyond individual symptom management to measure, strengthen, and cultivate the specific relational traits required for long-term recovery, social fitness, and human flourishing....

Read more

CVS Health Earns Two Gold and One Silver Stevie(R) Awards for Great Employers

August 11, 2026 10:20 AM

Originally published on CVS Health Company Newsroom CVS Health® (NYSE:CVS) announced that its AI Learning Academy earned two Golds and one Silver at the 11th Annual Stevie Awards for Great Employers, a global honor recognizing organizations for excellence in employee development, training and workplace culture. The company earned Gold in the Employee Upskill/Reskill Training and AI Workforce Innovation Team of the Year categories, and Silver in...

Read more

Solstice Health Revenue Grows 381% in Three Years, Propelling Company to No. 909 on Inc. 5000

August 11, 2026 9:40 AM

Solstice Health has been named to the 2026 Inc. 5000 for the second consecutive year after achieving 381% revenue growth from 2022 to 2025, propelling the Wisconsin healthcare company to No. 909 among the fastest-growing private companies in America. Solstice climbed 611 positions from its No. 1,520 ranking in 2025 and earned additional recognition as No. 4 in Milwaukee-Waukesha, No. 10 in Wisconsin and No. 110 nationally in Healthcare &...

Read more

Medical Care Technologies Advances Into $300B+ Food Logistics Sector with iPad Air-Ready AI Quality Platform (OTC PINK:MDCE)

August 11, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the expansion of its StrainScan Pro platform into the food logistics and distribution sector, positioning the proprietary AI vision software for enterprise deployment on iPad Air devices across warehouses, cold-chain facilities, and supply-chain nodes. The global food logistics market represents a substantial and growing segment of the broader food supply chain, with industry...

Read more

NCQA Receives Grant from The John A. Hartford Foundation to Advance Age-Friendly Care in Medicare Advantage Plans Nationwide

August 11, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) is proud to announce new funding from The John A. Hartford Foundation (JAHF) to develop and launch the NCQA Age-Friendly Health Plan program-the nation's first standardized program to evaluate how well Medicare Advantage plans deliver age‑friendly care. This initiative has the potential to influence plan behavior at scale, accelerate adoption of age-friendly practices across provider networks...

Read more

Kelyniam Global Announces Q2 2026 Financial Results

August 11, 2026 9:00 AM

Kelyniam Global (OTCID:KLYG), a leader in custom cranial implants, today reported its financial results for the six months ended June 30, 2026. The company delivered excellent performance, with strong revenue growth and a clear improvement in profitability. Financial Highlights for the Six Months Ended June 30, 2026 vs. 2025 Total revenue reached $1,904,547, up 39.6% from $1,364,432 in the prior-year period. Gross profit increased 41.5% to...

Read more

Vheda Health Named No. 1975 on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies

August 11, 2026 8:00 AM

Today Inc. announced Vheda Health has been ranked No. 1975 on the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. The list is the most prestigious ranking of the nation's most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such...

Read more

XVIVO Receives CE Certificates for Its Groundbreaking Heart Preservation Technology, Transforming Access to Life-Saving Transplants Across Europe

August 11, 2026 7:50 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO is proud to announce that its innovative heart preservation technology, XVIVO Heart Assist Transport system, has received CE certificates, making it available to any heart transplant center throughout Europe. This regulatory milestone marks a significant advancement both for XVIVO and for the broader field of heart transplantation. Today, only three out of ten donated hearts are used for...

Read more

Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation

August 11, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, August 28, 2026, at 4:00 p.m. Eastern Time. The August program, titled "Fourth Friday at Four - Zomedica International: Building a Global...

Read more

Who Is the Best FTM Top Surgeon in the U.S.?

August 11, 2026 6:00 AM

As gender-affirming care continues to expand across the United States, patients researching for FTM top surgery are increasingly comparing surgeons based on experience, available surgical techniques, individualized treatment planning and patient outcomes. These factors have become necessary during the decision-making process as Top surgery has evolved beyond a standardized approach. Among the surgeons recognized for specializing in...

Read more

Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies

August 11, 2026 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has signed a definitive Collaboration Agreement (the "Agreement") with Cellin Technologies OÜ ("Cellin"), a leading Estonian cell therapy company, for the manufacturing and clinical implementation of the Company's HG-CT-1 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia ("R/R AML") under the Hospital Exemption framework in Estonia. The...

Read more